What Is Vestibulodynia?

If sex has been painful at the point of entry, and you have been told that everything looks normal, vestibulodynia may be what is going on. It is one of the most common causes of painful intercourse in premenopausal women, and one of the most consistently missed.

The good news is that it is a recognized clinical condition with a well-developed evidence base for treatment. The less good news is that getting there often takes longer than it should.

The Anatomy Basics

The vestibule is the area just inside the labia minora, surrounding the opening of the vagina and the urethral opening. It is where penetration first makes contact, and it is extraordinarily rich in nerve endings. In vestibulodynia, those nerve endings become sensitized, meaning that stimuli that should not be painful, like light touch, tampon insertion, or vaginal penetration, are perceived as intensely painful.

What Makes It Different From Vulvodynia?

Vestibulodynia is actually a subtype of vulvodynia, specifically localized provoked vulvodynia. The distinction matters clinically. Generalized vulvodynia involves diffuse, often unprovoked pain across the vulva, while vestibulodynia is characterized by pain that is localized to the vestibule and reliably triggered by pressure or touch at that site.

Provoked vestibulodynia (PVD) is the most common subtype seen in clinical practice, and it is often what women are describing when they say penetration is impossible or excruciating. The diagnostic criterion is allodynia, meaning pain in response to stimuli that should not cause pain, at the vestibule (Bornstein et al., 2016).

How Common Is It?

Population-based studies estimate that PVD affects approximately 12% of premenopausal women, with some studies reporting even higher rates depending on the sample and methodology (Harlow et al., 2014). It is most commonly diagnosed in women between 20 and 40, though it can occur across the lifespan. Importantly, a significant proportion of women with PVD never receive a formal diagnosis despite years of symptoms.

What Causes It?

The etiology is multifactorial, which is a clinical way of saying there is rarely a single cause and the picture usually involves several interacting factors.

Neuroproliferative changes. Research has consistently shown that women with PVD have a higher density of nociceptive nerve fibers in the vestibular tissue compared to controls (Bohm-Starke et al., 1998). This is not a psychological finding. It is a structural one, visible on biopsy, and it helps explain why touch that should be neutral registers as pain.

Pelvic floor muscle dysfunction. Hypertonicity, meaning chronically elevated muscle tension in the pelvic floor, is almost universally present in women with PVD. Whether the muscle tension develops in response to anticipatory pain, or whether it contributes to the pain itself, the relationship is bidirectional and clinically significant (Reissing et al., 2004).

Central sensitization. The nervous system learns pain. With repeated painful experiences at the vestibule, the central nervous system can become sensitized, lowering the threshold for pain signaling more broadly. This is the same mechanism at work in other chronic pain conditions.

Hormonal factors. Early and extended use of combined oral contraceptives has been associated with increased risk for PVD in some studies, potentially through effects on vestibular tissue sensitivity and lubrication (Bouchard et al., 2002). This remains an area of active research.

Psychosocial factors. Pain catastrophizing, anxiety, and hypervigilance to pain cues have all been associated with greater pain severity and disability in PVD. These are not causes in the original sense, but they amplify and maintain the pain experience in ways that matter clinically.

What Does Treatment Look Like?

The evidence base for PVD is actually one of the stronger ones in sexual medicine, which is somewhat reassuring given how long this condition went unrecognized.

Pelvic floor physiotherapy has robust evidence and is typically considered a first-line intervention. Techniques include manual therapy, biofeedback, and progressive desensitization. Research comparing physiotherapy to surgery found comparable outcomes, with physiotherapy preferred for its non-invasive profile and lower risk (Bergeron et al., 2001).

Cognitive-behavioural therapy (CBT) has demonstrated efficacy in multiple randomized controlled trials, with improvements in pain intensity, sexual function, and psychological wellbeing (Bergeron et al., 2016). The mechanism appears to involve reducing pain catastrophizing and fear-avoidance behaviour.

Vestibulectomy, a surgical procedure that removes the affected vestibular tissue, has the strongest evidence for pain reduction in women with primary PVD who have not responded to conservative treatments, with success rates reported between 70% and 90% in well-designed studies (Goldstein et al., 2006).

Topical treatments including lidocaine and low-dose naltrexone have evidence supporting their use as adjuncts. Gabapentin and amitriptyline are also used in some clinical contexts.

A Word on Prognosis

This is not a condition you are destined to manage forever. Many women who receive appropriate, coordinated treatment experience meaningful and sometimes complete resolution of symptoms. The pathway is not always linear, and it often requires patience and the right team. But the evidence is genuinely encouraging.

If you are experiencing vestibulodynia or provoked vestibulodynia and looking for psychological support as part of your care, you can learn more about how I approach sexual and pelvic pain treatment in Victoria, BC and virtually across BC and Alberta. I work collaboratively with pelvic floor physiotherapists and specialist gynaecologists, and I address the psychological dimensions of this condition that coordinated medical care alone often doesn't cover. If you are not yet ready for individual therapy, my online workshop Managing Sexual Pain, which is a self-paced resource covering the most common questions I hear from women with conditions like vestibulodynia, including understanding your diagnosis, navigating treatment, and rebuilding intimacy. Get in touch if you would like to talk through what support might look like for you.

References

Bergeron, S., Binik, Y. M., Khalife, S., Pagidas, K., Glazer, H. I., Meana, M., & Amsel, R. (2001). A randomized comparison of group cognitive-behavioural therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain, 91(3), 297–306.

Bergeron, S., Corsini-Munt, S., Aerts, L., Rancourt, K., & Rosen, N. O. (2016). Female sexual pain disorders: A review of the literature on etiology and treatment. Current Sexual Health Reports, 7(3), 159–169.

Bohm-Starke, N., Hilliges, M., Falconer, C., & Rylander, E. (1998). Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecologic and Obstetric Investigation, 46(4), 256–260.

Bornstein, J., Goldstein, A. T., Stockdale, C. K., Bergeron, S., Pukall, C., Zolnoun, D., & Coady, D. (2016). 2015 ISSVD, ISSWSH and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. Obstetrics & Gynecology, 127(4), 745–751.

Bouchard, C., Brisson, J., Fortier, M., Morin, C., & Blanchette, C. (2002). Use of oral contraceptive pills and vulvar vestibulitis: A case-control study. American Journal of Epidemiology, 156(3), 254–261.

Goldstein, A. T., Klingman, D., Christopher, K., Johnson, C., & Marinoff, S. C. (2006). Surgical treatment of vulvar vestibulitis syndrome: Outcome assessment derived from a postoperative questionnaire. Journal of Sexual Medicine, 3(5), 923–931.

Harlow, B. L., Kunitz, C. G., Nguyen, R. H., Rydell, S. A., Turner, R. M., & MacLehose, R. F. (2014). Prevalence of symptoms consistent with a diagnosis of vulvodynia. American Journal of Obstetrics & Gynecology, 210(1), 40.e1–40.e8.

Reissing, E. D., Brown, C., Lord, M. J., Binik, Y. M., & Khalife, S. (2004). Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome. Journal of Psychosomatic Obstetrics & Gynecology, 26(2), 107–113.

Sonnet 4.6